Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | MGLL | Q99685 | 10/20 | 0.47 |
| ▸ | FAAH | O00519 | 5/20 | 0.44 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.36 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.36 |
| ▸ | NSD2 | O96028 | 1/20 | 0.36 |
| ▸ | G6PD | P11413 | 1/20 | 0.36 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26623027 | 0.86 | ALDH1A1 (0.67) | PKMALDH1A1MGLLFAAHDDAH1 | |
| SCHEMBL8198697 | 0.86 | ALDH1A1 (0.52) | PKMALDH1A1MGLLFAAHHSP90AA1 | |
| SCHEMBL28882413 | 0.81 | HSP90AA1 (0.43) | PKMALDH1A1MGLLFAAHDDAH1 | |
| SCHEMBL23327953 | 0.81 | ALDH1A1 (0.54) | PKMALDH1A1MAPK1HPGD | |
| SCHEMBL6045666 | 0.80 | MGLL (0.38) | PKMALDH1A1MGLLFAAHDDAH1 | |
| SCHEMBL2169006 | 0.80 | ALDH1A1 (0.50) | PKMALDH1A1MGLLFAAHHSP90AA1 | |
| SCHEMBL1824376 | 0.74 | DNMT1 (0.48) | PKMALDH1A1MGLLFAAHNPSR1 | |
| SCHEMBL4429188 | 0.73 | ALDH1A1 (0.50) | PKMALDH1A1MGLLFAAHHSP90AA1 | |
| SCHEMBL19309442 | 0.73 | MGLL (0.46) | PKMALDH1A1MGLLFAAHDDAH1 | |
| SCHEMBL8510655 | 0.71 | MGLL (0.49) | PKMALDH1A1MGLLFAAHDDAH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1592 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3765188-B1 | SURFACE FUNCTIONALISED MATERIALS FOR SAMPLING BIOLOGICAL MOLECULES | JONES PAUL ANTONIO (GB) | 2025-04-16 | — | — | EP | claimed |
| WO-2025054602-A1 | PROTEIN FOR THE SEROLOGICAL DETECTION OF STREPTOCOCCUS EQUI SUBSPECIES EQUI EXPOSURE OR INFECTION | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2025-03-13 | — | — | WO | claimed |
| US-11712423-B2 | Methods and compositions for modifying mucous membranes | ABBOTT NICHOLAS L (US) | 2023-08-01 | — | — | US | claimed |
| US-10155046-B2 | Activated sialic acid derivatives for protein derivatisation and conjugation | LIPOXEN TECHNOLOGIES LIMITED (GB) | 2018-12-18 | — | — | US | claimed |
| EP-2686019-B1 | CONJUGATED MOLECULES COMPRISING A PEPTIDE DERIVED FROM THE CD4 RECEPTOR COUPLED TO A POLYANIONIC POLYPEPTIDE FOR THE TREATMENT OF AIDS | PASTEUR INSTITUT (FR) | 2017-03-01 | — | — | EP | claimed |
| EP-1853634-B1 | ACTIVATED SIALIC ACID DERIVATIVES FOR PROTEIN DERIVATISATION AND CONJUGATION | LIPOXEN TECHNOLOGIES LTD (GB) | 2016-08-10 | — | — | EP | claimed |
| EP-1776389-B1 | SIALIC ACID DERIVATIVES | LIPOXEN TECHNOLOGIES LTD (GB) | 2016-06-29 | — | — | EP | claimed |
| US-20160120993-A1 | Activated Sialic Acid Derivatives For Protein Derivatisation And Conjugation | LIPOXEN TECHNOLOGIES LIMITED (GB) | 2016-05-05 | — | — | US | claimed |
| US-9216227-B2 | Activated sialic acid derivatives for protein derivatisation and conjugation | LIPOXEN TECHNOLOGIES LIMITED (GB) | 2015-12-22 | — | — | US | claimed |
| EP-2478049-B1 | A POLYMER SUPPORT | UNIV CAPE TOWN (ZA) | 2015-02-25 | — | — | EP | claimed |
| WO-1999040214-A2 | NUCLEIC ACID DELIVERY VEHICLES | GENZYME CORPORATION (US) | 1999-08-12 | — | — | WO | claimed |
| EP-0457250-B1 | Novel bifunctional linking compounds, conjugates and methods for their production | BRISTOL MYERS SQUIBB CO (US) | 1999-07-14 | — | — | EP | claimed |
| EP-0633029-B1 | Further improvements relating to drug delivery systems | CANCER RES CAMPAIGN TECH (GB) | 1997-11-26 | — | — | EP | claimed |
| EP-0396116-B1 | Covalent attachment of specific binding members to a solid phase | ABBOTT LAB (US) | 1997-02-05 | — | — | EP | claimed |
| EP-0366770-B1 | LIPOSOMES COUPLED TO HORMONES | VESTAR INC (US) | 1994-02-09 | — | — | EP | claimed |
| EP-0366770-A1 | LIPOSOMES COUPLED TO HORMONES. | SANDOZ AG (CH) | 1990-05-09 | — | — | EP | claimed |
| WO-1989011270-A1 | LIPOSOMES COUPLED TO HORMONES | SANDOZ AG (CH) | 1989-11-30 | — | — | WO | claimed |
| US-4657853-A | Immunoassays utilizing covalent conjugates of polymerized enzyme and antibody | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-04-14 | — | — | US | claimed |
| EP-0184710-A2 | Magnetic microspheres | BAYER AG (DE) | 1986-06-18 | — | — | EP | claimed |
| EP-0175560-A2 | Immunoassays utilizing covalent conjugates of polymerized enzyme and antibody | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-03-26 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10155046-B2 | Activated sialic acid derivatives for protein derivatisation and conjugation | NANS, SPAST, NEU1 | PKM 2149/4885ALDH1A1 922/4885MGLL 4237/4885 |
| US-20160120993-A1 | Activated Sialic Acid Derivatives For Protein Derivatisation And Conjugation | NANS, SPAST, NEU1 | PKM 2149/4885ALDH1A1 922/4885MGLL 4237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.